COMPANY PROFILE / #3601
GrayMatters Health
Haifa, IsraelVenture Capital-Backed
OVERVIEW
Developer of a health technology designed to develop a self-neuromodulation treatment based on brain biomarkers associated with mental health disorders. The company's digital therapeutics follow the self-regulation of brain processes to solve the issues related to mental health and neurologic disorders and mental healthcare professionals with a neuroscience-based technology that bridges the gaps of efficacy, safety, and accessibility for healthcare common procedure coding system and patients, enabling patients suffering from neurological disorders to treat their diseases in a hassle-free manner.
已融资18.97
最新估值32.76
员工数32
成立年份2018
公司概况
- Companies
- GrayMatters Health
- Description
- Developer of a health technology designed to develop a self-neuromodulation treatment based on brain biomarkers associated with mental health disorders. The company's digital therapeutics follow the self-regulation of brain processes to solve the issues related to mental health and neurologic disorders and mental healthcare professionals with a neuroscience-based technology that bridges the gaps of efficacy, safety, and accessibility for healthcare common procedure coding system and patients, enabling patients suffering from neurological disorders to treat their diseases in a hassle-free manner.
- Website
- www.graymatters-health.com
- HQ Location
- Haifa, Israel
- Year Founded
- 2018
- Keywords
- brain biomarkers, digital therapy platform, health technology, machine learning technology, mental health care, mental healthcare technology, ptsd treatment, software device
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 18.97
- First Financing Date
- 04-Mar-2020
- First Financing Size
- 3.55
- First Financing Valuation
- 8.02
- Last Financing Date
- 09-Oct-2025
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 1.05
- Last Financing Valuation
- —
- Last Financing Status
- Completed
- Last Known Valuation
- 32.76
- Last Known Valuation Date
- 16-Apr-2024
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 40.15
- Valuation Estimate Growth Rate
- 22.56%
- Active Investors
- 28DIGITAL, Corundum Neuroscience, Endless Frontier Labs, European Innovation Council, HiCenter, Horizon Europe, J-Impact, Joyance Partners, J-Ventures, Marius Nacht, Otsuka Medical Devices
- # Active Investors
- 11
- Acquirers
- —
团队与联系人
- Employees
- 32
- Employee Growth %
- -5.88%
- Employee History
- 2026: 32, 2025: 34, 2024: 29, 2023: 24, 2022: 18, 2021: 11, 2020: 8, 2019: 3
- Primary Contact
- Oded Kraft
- Primary Contact Title
- Co-Founder, Chief Executive Officer & President
- Primary Contact Email
- oded@graymatters.health
- Primary Contact Phone
- +972 (0)52 517 3030
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.00%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 13
- Size Multiple
- 2.08x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 70
- Majestic Referring Domains
- 54
- SimilarWeb Unique Visitors
- 328
- SimilarWeb Unique Visitors Change
- -16
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 19%
- Success Probability Over Time – 3 Year
- 39%
- Success Probability Over Time – 5 Year
- 52%
记录来源：public.companies · 原始序号 #3601 · 所有字段均按数据库原值展示。